Details

Autor(en) / Beteiligte

• Lurienne, Lise
• Bandinelli, Pierre-Alain
• Galvain, Thibaut
• Coursel, Charles-Alexis
• Oneto, Caterina
• Feuerstadt, Paul

Titel

Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey

Ist Teil von

• Journal of patient-reported outcomes, 2020-02, Vol.4 (1), p.14-14, Article 14

Ort / Verlag

Cham: Springer International Publishing

Erscheinungsjahr

2020

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Background Although the incidence, severity and mortality of Clostridioides ( Clostridium ) difficile infection (CDI) have been increasing, patients’ quality of life changes resulting from CDI have not been studied thoroughly. This study aimed at exploring the consequences of CDI on quality of life through patients’ perspective. Methods An observational, cross-sectional study involving 350 participants with a self-reported CDI diagnosis was conducted through an online self-administered survey. Participants were grouped into those who had active disease (“Current CDI”) and those who had a history of CDI (“Past CDI”). Results One hundred fifteen participants (33%) reported Current CDI and 235 (67%) reported Past CDI. A large majority of participants admitted that their daily activities were impacted by the infection (93.9% and 64.7% of Current and Past CDI respondents respectively, p  < 0.05). Physical and psychological consequences of CDI were experienced by 63.5% and 66.1% of participants with active CDI. Despite the infection being cleared, these consequences were still frequently experienced in Past CDI cohort with similar rates (reported by 73.2% of respondents for both, physical consequences p  = 0.08; psychological consequences p  = 0.21). After the infection, 56.6% of respondents noted that post-CDI symptoms remained; 40.9% believed they would never get rid of them. Conclusions While the societal burden of CDI is well described in the literature, our study is one of the first aimed at understanding the major burden of CDI on quality of life. Our results highlight the long-lasting nature of CDI and further reinforce the need for enhanced therapeutics in the prevention and treatment of this devastating infection.